Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jennifer Morawiak"'
Autor:
Abdelkader Seroutou, Yan Ji, Marios Giannakis, Margaret E. McLaughlin, David Smith, Elena Garralda, Filip Janku, Jennifer Morawiak, Ulka N. Vaishampayan, Roisin M. Connolly, Jason R. Dobson, Sinead Dolan, Guillem Argiles, Jordi Rodon, Susan Moody, Maja J.A. de Jonge
Publikováno v:
Cancer Research. 78:CT175-CT175
Background: Dysregulated Wnt/β-catenin signaling has been linked to several cancers, including pancreatic cancer (PC) and colorectal cancer (CRC). WNT974 (formerly LGK974) - a first-in-class, selective, oral inhibitor of Porcupine (an O-acyltransfer
Autor:
Roisin M. Connolly, Guillem Argiles, Patricia LoRusso, Jennifer Morawiak, Jordi Rodon, Michael Palmer, Filip Janku, Yan Ji, Margaret E. McLaughlin, Andrea P. Myers, Maya de Jonge, Ulka N. Vaishampayan, Shu-Fang Hsu Schmitz
Publikováno v:
Molecular Cancer Therapeutics. 14:C45-C45
Background: Aberrant Wnt pathway activation is critical for initiation and maintenance of multiple tumor types, yet therapeutic inhibition of Wnt/β-catenin signaling has been challenged by the lack of tractable targets. WNT974 is an oral investigati
Autor:
Sadhana Jain, Ping Li, Stephen Schmidt, Rebecca Roy, Linda Chee, Michael E. Bembenek, Thomas F. Parsons, Andrea Prack, Jennifer Morawiak
Publikováno v:
Assay and drug development technologies. 1(4)
We have characterized a recombinantly expressed N-terminally tagged GST fusion of the tyrosine kinase domain of human EphB3. The EphB3 kinase domain was shown to phosphorylate a group of synthetic tyrosine-containing peptides derived from a proprieta
Autor:
Michael E. Bembenek, Stephen Schmidt, Ping Li, Jennifer Morawiak, Andrea Prack, Sadhana Jain, Rebecca Roy, Thomas Parsons, Linda Chee
Publikováno v:
Assay & Drug Development Technologies; Aug2003, Vol. 1 Issue 4, p555-563, 9p